Valrubicin: an alternative to radical cystectomy for carcinoma in situ of the bladder.
Treatment options for patients who fail BCG therapy are limited. While cystectomy may be curative, not all patients can withstand the medical and/or psychologic stresses associated with surgery or resection. Valrubicin represents a safe and effective second-line intravesical therapy.